|
[1]
|
Kakoly, N., Moran, L., Teede, H. and Joham, A. (2018) Cardiometabolic Risks in PCOS: A Review of the Current State of Knowledge. Expert Review of Endocrinology & Metabolism, 14, 23-33. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Zeng, X., Xie, Y., Liu, Y., Long, S. and Mo, Z. (2020) Polycystic Ovarian Syndrome: Correlation between Hyperandrogenism, Insulin Resistance and Obesity. Clinica Chimica Acta, 502, 214-221. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
多囊卵巢综合征诊治路径专家共识编写组, 李蓉, 段洁, 等. 多囊卵巢综合征诊治路径专家共识[J]. 中华生殖与避孕杂志, 2023(4): 337-345.
|
|
[4]
|
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中华糖尿病杂志, 2021, 13(4): 315-409.
|
|
[5]
|
袁莹莹, 赵君利. 多囊卵巢综合征流行病学特点[J]. 中国实用妇科与产科杂志, 2019(35): 261-264.
|
|
[6]
|
尹静. 肥胖型与非肥胖型多囊卵巢综合征患者超声参数、内分泌指标及胰岛功能的差异性分析[J]. 临床医学, 2020, 40(2): 81-83.
|
|
[7]
|
Livadas, S., Androulakis, I., Angelopoulos, N., Lytras, A., Papagiannopoulos, F. and Kassi, G. (2020) Liraglutide Administration Improves Hormonal/Metabolic Profile and Reproductive Features in Women with HAIR-AN Syndrome. Endocrinology, Diabetes & Metabolism Case Reports, 2020, 214-221. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Barber, T.M. and Franks, S. (2021) Obesity and Polycystic Ovary Syndrome. Clinical Endocrinology, 95, 531-541. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
帅祥煜, 任燕丽. 人体不同部位脂肪与肥胖相关疾病的关系研究概述[J]. 体育医学, 2021(5): 101-102.
|
|
[10]
|
王婵. 脂肪组织在多囊卵巢综合征中的研究进展[J]. 中国妇幼保健, 2018, 33(22): 5297-5300.
|
|
[11]
|
苏汇茹. 超声测量各部位脂肪厚度与肥胖相关疾病的相关性研究[D]: [硕士学位论文]. 成都: 成都医学院, 2020.
|
|
[12]
|
Matsuzaki, T., Tungalagsuvd, A., Iwasa, T., Munkhzaya, M., Yano, K., Mayila, Y., et al. (2017) Clinical Outcome of Various Metformin Treatments for Women with Polycystic Ovary Syndrome. Reproductive Medicine and Biology, 16, 179-187. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Rocha, A.L., Oliveira, F.R., Azevedo, R.C., Silva, V.A., Peres, T.M., Candido, A.L., et al. (2019) Recent Advances in the Understanding and Management of Polycystic Ovary Syndrome. F1000 Research, 8, Article 565. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
沈涌海, 施新颜, 邱媛, 等. 多囊卵巢综合征患者血清FAI与AMH、IR的相关性研究[J]. 预防医学, 2018, 30(5): 467-470.
|
|
[15]
|
孙淼, 张晓颖, 李洋洋, 等. 多囊卵巢综合征低度慢性炎症与肥胖的关系[J]. 河北医科大学学报, 2021, 42(7): 823-826.
|
|
[16]
|
Taylor, E.B. (2021) The Complex Role of Adipokines in Obesity, Inflammation, and Autoimmunity. Clinical Science, 135, 731-752. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Kim, J., Kim, J., Jo, M., Cho, E., Ahn, S., Kwon, Y., et al. (2022) The Roles and Associated Mechanisms of Adipokines in Development of Metabolic Syndrome. Molecules, 27, Article 334. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
褚冉, 梁毓. 多囊卵巢综合征患者血清脂肪因子Asprosin、Apelin-13表达及与胰岛素抵抗关系[J]. 中国计划生育学杂志, 2022, 30(4): 846-850.
|
|
[19]
|
de Medeiros, S.F., de Medeiros, M.A.S., Barbosa, B.B. and Yamamoto, M.M.W. (2021) The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome. Metabolic Syndrome and Related Disorders, 19, 18-25. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
刘丽, 张燕, 李萍, 等. 超重肥胖PCOS患者胰岛素抵抗与人体成分指标相关性研究[J]. 宁夏医学杂志, 2021, 43(12): 1096-1099.
|
|
[21]
|
董梦姣, 张杉杉, 李程, 等. 多囊卵巢综合征患者肥胖指标对胰岛素抵抗的预测价值[J]. 疑难病杂志, 2021, 20(8): 811-815.
|
|
[22]
|
Liu, Y., Ding, Q., et al. (2017) Correlation between Osteo-Calcin and Visceral Fatareain over Weight and Obese Male Population. International Journal of Clinical and Experimental Medicine, 10, 6980-6986.
|